Goal 4: Forward plan to maintain a vibrant and active urogenital cancer trials
ANZUP actively engages, collaborates, and expands its stakeholder relationships through various means. Crucially, the funding agreement with the Australian Government through the Cancer Australia Support for Clinical Trials continues to support ANZUP’s infrastructure.
Donors, volunteers, philanthropists, corporate partners, and other key stakeholders remain a significant focus for ANZUP and especially the Partnerships and Engagement role. ANZUP continues to develop, manage and retain these important relationships.
Collaborative links have played a significant role in ANZUP’s ability to operate at a high capacity. This is demonstrated by the four co-badged trials with other Cancer Cooperative Trials Groups (CCTGs) and our membership of the Executive Officers Network (EON) and Clinical Trials Consumer Network (CTCN). The CTCN shares information amongst the groups’ Consumer Advisory Panels (CAPs) and EON reinforces links between groups by the sharing of concepts and resources.
In 2022/23, ANZUP collaborated with the NHMRC Clinical Trials Centre (CTC) at the University of Sydney to conduct 10 clinical trials. In addition, ANZUP partnered with the Centre for Biostatistics and Clinical Trials (BaCT) to conduct 4 clinical trials and with the Walter and Eliza Hall Institute of Medical Research (WEHI) for 1 trial. These established affiliations guarantee vigorous processes on trial development and operations.
ANZUP’s Key Relationships include:
- Australia & New Zealand Urological Nurses Society (ANZUNS) – represented on the ANZUP SAC by Kath Schubach
- Australian Clinical Trials Alliance (ACTA)
- Cancer Australia
- Cancer Councils
- Clinical Oncology Society of Australia (COSA)
- Colleges (e.g. RACP, RANZCR, RACS)
- Kidney Health Australia
- Medical Oncology Group of Australia
- National Cancer Cooperative Trials Groups
- Prostate Cancer Foundation Australia (PCFA)
- TROG (Trans Tasman Radiation Oncology Group) Cancer Research
- Urological Society of Australia & New Zealand (USANZ)
- Walter and Eliza Hall Institute of Medical Research (WEHI)
International Partnerships and Collaborations
- Alliance for Clinical Trials in Oncology
- Canadian Cancer Trials Group (CCTG)
- Cancer Research UK
- Cancer Trials Ireland (CTI)
- Children’s Oncology Group (COG)
- Dana-Farber Cancer Institute
- European Organisation for Research and Treatment of Cancer (EORTC)
- Medical Research Council (MRC) UK
- National Cancer Institute
- Prostate Cancer Clinical Trials Consortium (PCCTC)
- Prostate Cancer Foundation New Zealand (PCFNZ)
ANZUP’s multidisciplinary membership remains the most valuable stakeholder relationship. For members, ANZUP delivers an annual calendar of education and networking opportunities. In 2022/23, this included the Idea Generation Workshops, Prostate Cancer Rapid Fire Program and the ASM, educational workshops and events, grant opportunities, scholarships, fellowships and awards. These initiatives allow ANZUP to continuously support fellows, trainees and junior researchers on an ongoing basis. By connecting them with experts in their respective fields, these events enable skill development, knowledge enhancement, critical evaluation of research areas, and active participation in the trial development process. Our collaboration with PCFA to improve access to, and funding for, prostate cancer trials has strengthened another crucial relationship.
Regular email, print and social media updates are frequently distributed and shared with the ANZUP membership. Being an ANZUP member provides individuals with the means to stay informed about the latest developments in GU clinical trials research, networking opportunities, and the chance to attend educational sessions.